SFX by Ex Libris Inc.

Title:	HIV: The next shot
Source:	Nature [0028-0836] Hayden, E C yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gurunathan, S. "Use of predictive markers of HIV disease progression in vaccine trials." Vaccine 27.14 (2009): 1997-2015.
description	2.	Sasako, M. "D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer." New England Journal of Medicine, The 359.5 (2008): 453-62.
description	3.	Lee, Soo Hyeon H. "Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide." Biochemical and biophysical research communications 357.2 (2007): 511-516.
description	4.	Burton, Dennis R R. "Toward an AIDS vaccine." Science 320.5877 (2008): 760-4.
description	5.	Wang, S. "Targeting the carbohydrates on HIV-1: interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN." Proceedings of the National Academy of Sciences of the United States of America 105.10 (2008): 3690-5.
description	6.	Johnston, Margaret I I. "An HIV vaccine--evolving concepts." The New England journal of medicine 356.20 (2007): 2073-81.
description	7.	Bernstein, A. "AIDS and the next 25 years." Science 320.5877 (2008): 717-717.
description	8.	Johnston, Margaret I. "Current concepts: An HIV vaccine - Evolving concepts." The New England journal of medicine 356.20 (2007): 2073-2081.
description	9.	Brusic, Isaac G. "Optimizing vaccine development." Cellular microbiology 13.7 (2011): 934-42.
description	10.	McKinnon, Lyle R. "HIV Vaccine Efficacy Trials: A Brief History, and Options for Going Forward." AIDS reviews 12.4 (2010): 209-217.
description	11.	Choi, S. "Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide." Biotechnology progress 26.1 (2009): 57-63.
description	12.	D'Adda, G. "ARV Treatment and Time Allocation to Household Tasks: Evidence from Kenya." African development review 21.1 (2009): 180-208.
description	13.	Mothe, B. "Virological, immune and host genetics markers in the control of HIV infection." Disease Markers 27.3-4 (2009): 105-120.
description	14.	Balzarini, J. "The regulation of HIV-1 transcription: Molecular targets for chemotherapeutic intervention." Medicinal research reviews 26.5 (2006): 595-625.
description	15.	Slack, C. "Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective." Social science & medicine 60.6: 1197-1208.
description	16.	Kim, SH H. "Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate." Bioconjugate chemistry 17.1 (2006): 241-244.
description	17.	Sekaly, RP P. "The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?" The Journal of experimental medicine 205.1 (2008): 7-12.
description	18.	Moertel, C G G. "Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer." The Lancet 2.7626 (1969): 865-867.
description	19.	Thein, Hla-Hla H. "Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression." Hepatology 48.2 (2008): 418-31.
description	20.	rn, J. "The Self-Organizing QUANTUM UNIVERSE." Scientific American 299.1 (2008): 42-49.